- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Common Symptoms Seen With Bronchiectasis
Panelists discusses how bronchiectasis differs from other respiratory diseases like asthma and COPD through symptoms, imaging findings, and pathophysiological mechanisms.
EP: 1.Common Symptoms Seen With Bronchiectasis
EP: 2.Examining The Pathophysiology Of Bronchiectasis
EP: 3.Exploring the Impact of Bronchiectasis Exacerbations
EP: 4.Analyzing Treatment-Refractory Patients
EP: 5.Common Causes of Bronchiectasis
EP: 6.Airway Clearance Techniques and Antibiotics for Patients With Bronchiectasis
EP: 7.Unmet Needs for Bronchiectasis Exacerbations
EP: 8.Ideal Candidates for Bronchiectasis Surgeries
EP: 9.Preventive Strategies and Emerging Therapies for Bronchiectasis
EP: 10.Current Challenges in the Management of Bronchiectasis
EP: 11.The Effects of the Heterogeneity of Bronchiectasis
EP: 12.Novel Treatment Options for Bronchiectasis
EP: 13.Important Clinical Considerations for Patients With Bronchiectasis
EP: 14.Final Thoughts on Bronchiectasis Management
Clinical Brief: Understanding Bronchiectasis Pathophysiology
Main Discussion Topics
- Symptoms of bronchiectasis include cough, sputum production, and shortness of breath, similar to other respiratory diseases but with distinguishing features
- Bronchiectasis involves irreversible, dilated airways visible on imaging, unlike asthma (which is more reversible) and COPD (which presents with emphysema)
- Diagnostic differentiation between bronchiectasis, asthma, and COPD is important despite symptom overlap
Key Points for Physicians
- Patients with bronchiectasis typically present with more copious mucus production and recurrent infections
- On imaging, bronchiectasis appears as irreversibly dilated airways
- COPD typically presents with emphysema (destroyed alveolar areas) on imaging
- Asthma has day-to-day or diurnal variability and is generally more reversible
Notable Insights
Bronchiectasis is structurally distinct from both asthma and COPD despite sharing similar respiratory symptoms, making accurate diagnosis crucial for appropriate management.
Clinical Significance
Understanding the pathophysiological differences between bronchiectasis, asthma, and COPD is essential for accurate diagnosis and targeted management strategies.
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
August 6th 2025Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared with immune checkpoint inhibitors plus chemotherapy.
Read More
